Advanced search
Publication Cover
The Journal of Maternal-Fetal & Neonatal Medicine Volume 25, 2012 - Issue 9
Submit an article Journal homepage
220
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Assessing the quality of evidence for preterm labor tocolytic trials

David M. HaasDepartment of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN, USACorrespondence[email protected]
,
Page KirkpatrickDepartment of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN, USA
,
Jennifer J. McIntoshDepartment of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN, USA
&
Deborah M. CaldwellSchool of Social and Community Medicine, University of Bristol, Bristol, UK
Pages 1646-1652 | Received 05 Jul 2011, Accepted 13 Dec 2011, Published online: 23 Jan 2012

References

  • Haas DM, Imperiale TF, Kirkpatrick PR, Klein RW, Zollinger TW, Golichowski AM. Tocolytic therapy: a meta-analysis and decision analysis. Obstet Gynecol 2009;113:585–594.
  • Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev 2000;(2): CD000065.
  • Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev 2002; 2: CD001060.
  • Anotayanonth S, Subhedar NV, Garner P, Neilson JP, Harigopal S. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev 2004: CD004352.
  • King J, Flenady V, Cole S, Thornton S. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev 2005;(2): CD001992.
  • King JF, Flenady VJ, Papatsonis DN, Dekker GA, Carbonne B. Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev 2003(1): CD002255.
  • Papatsonis D, Flenady V, Cole S, Liley H. Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database Syst Rev 2005;(3): CD004452.
  • Higgins JP, Green S editors Cochrane Handbook for systematic reviews of interventions 5.1.0 [updated March 2011]. Chapter 8: Available from www.cochrane-handbook.org.; 2011.
  • Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357:1191–1194.
  • Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. QUOROM Group. Br J Surg 2000;87:1448–1454.
  • Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.